Financial Ratios DiaSorin S.p.A.
Equities
DIA
IT0003492391
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.42 EUR | -0.94% |
|
+7.37% | +4.08% |
| 06-05 | Milan stock market opens flat ahead of US data; profit-taking hits Diasorin and STM, Erg rallies | RE |
| 06-05 | European markets set for mixed open following Dow record | AN |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 12.3 | 7.06 | 4.33 | 5.12 | 5.56 | |||||
Return on Total Capital | 14.66 | 8.31 | 5.12 | 6.01 | 6.63 | |||||
Return On Equity % | 26.74 | 16.63 | 10.37 | 11.21 | 8.89 | |||||
Return on Common Equity | 26.8 | 16.7 | 10.46 | 11.27 | 9.19 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 66.64 | 66.17 | 64.55 | 65.99 | 65.06 | |||||
SG&A Margin | 24.66 | 30.51 | 36.09 | 34.98 | 34.16 | |||||
EBITDA Margin % | 41.63 | 35.41 | 29.04 | 30.79 | 30.96 | |||||
EBITA Margin % | 38.54 | 31.86 | 24.62 | 27.22 | 27.49 | |||||
EBIT Margin % | 35.61 | 27.53 | 19.99 | 22.5 | 22.98 | |||||
Income From Continuing Operations Margin % | 25.11 | 17.64 | 13.8 | 15.78 | 12.55 | |||||
Net Income Margin % | 25.13 | 17.7 | 13.92 | 15.87 | 13.02 | |||||
Net Avail. For Common Margin % | 25.13 | 17.7 | 13.92 | 15.87 | 13.02 | |||||
Normalized Net Income Margin | 21.39 | 16.13 | 11.79 | 13.25 | 13.89 | |||||
Levered Free Cash Flow Margin | 8.53 | 10.59 | 19.94 | 17.16 | 19.15 | |||||
Unlevered Free Cash Flow Margin | 9.51 | 12.16 | 21.48 | 18.55 | 20.38 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.55 | 0.41 | 0.35 | 0.36 | 0.39 | |||||
Fixed Assets Turnover | 5.94 | 5 | 4.38 | 4.49 | 4.53 | |||||
Receivables Turnover (Average Receivables) | 6.46 | 6.22 | 5.49 | 6.03 | 6.04 | |||||
Inventory Turnover (Average Inventory) | 1.69 | 1.52 | 1.31 | 1.22 | 1.23 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.21 | 3.1 | 3.07 | 3.51 | 1.55 | |||||
Quick Ratio | 2.11 | 1.8 | 1.9 | 2.12 | 0.82 | |||||
Operating Cash Flow to Current Liabilities | 1.34 | 1.12 | 0.97 | 1.3 | 0.68 | |||||
Days Sales Outstanding (Average Receivables) | 56.51 | 58.68 | 66.53 | 60.71 | 60.38 | |||||
Days Outstanding Inventory (Average Inventory) | 216.27 | 239.58 | 278.89 | 299.34 | 296.62 | |||||
Average Days Payable Outstanding | 52.77 | 73.54 | 89.89 | 84.87 | 93.16 | |||||
Cash Conversion Cycle (Average Days) | 220.02 | 224.71 | 255.53 | 275.18 | 263.85 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 102.24 | 88.96 | 77.55 | 56.4 | 50.19 | |||||
Total Debt / Total Capital | 50.55 | 47.08 | 43.68 | 36.06 | 33.42 | |||||
LT Debt/Equity | 94.65 | 81.06 | 70.42 | 53.74 | 33.86 | |||||
Long-Term Debt / Total Capital | 46.8 | 42.9 | 39.66 | 34.36 | 22.54 | |||||
Total Liabilities / Total Assets | 57.66 | 55.41 | 52.11 | 45.57 | 45.12 | |||||
EBIT / Interest Expense | 22.7 | 11 | 8.11 | 10.11 | 11.73 | |||||
EBITDA / Interest Expense | 26.99 | 14.5 | 12.18 | 14.27 | 16.33 | |||||
(EBITDA - Capex) / Interest Expense | 23.47 | 12.94 | 10.57 | 12.29 | 13.69 | |||||
Total Debt / EBITDA | 2.67 | 2.74 | 3.46 | 2.69 | 2.07 | |||||
Net Debt / EBITDA | 1.9 | 1.96 | 2.36 | 1.69 | 1.52 | |||||
Total Debt / (EBITDA - Capex) | 3.07 | 3.07 | 3.99 | 3.13 | 2.47 | |||||
Net Debt / (EBITDA - Capex) | 2.18 | 2.19 | 2.72 | 1.96 | 1.81 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 40.43 | 9.98 | -15.64 | 3.24 | 0.81 | |||||
Gross Profit, 1 Yr. Growth % | 36.8 | 9.2 | -17.7 | 5.54 | -0.54 | |||||
EBITDA, 1 Yr. Growth % | 37.38 | -6.46 | -30.82 | 6.47 | 1.51 | |||||
EBITA, 1 Yr. Growth % | 37.38 | -9.08 | -34.82 | 10.49 | 1.97 | |||||
EBIT, 1 Yr. Growth % | 33.7 | -14.97 | -38.76 | 11.65 | 3.18 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 25.15 | -22.73 | -33.99 | 18.01 | -19.79 | |||||
Net Income, 1 Yr. Growth % | 25.46 | -22.53 | -33.65 | 17.68 | -17.27 | |||||
Normalized Net Income, 1 Yr. Growth % | 29.69 | -16.68 | -38.34 | 11.74 | 5.88 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 20 | -23.15 | -30.9 | 17.42 | -15.35 | |||||
Accounts Receivable, 1 Yr. Growth % | 31.33 | 1.12 | -9.76 | -1.95 | 3.08 | |||||
Inventory, 1 Yr. Growth % | 55.86 | 2.84 | 2.94 | 9.05 | -2.74 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 96.59 | -2.81 | -4.53 | 5.88 | -5.71 | |||||
Total Assets, 1 Yr. Growth % | 159.23 | 5.48 | -5.77 | 2.91 | -13.06 | |||||
Tangible Book Value, 1 Yr. Growth % | -140.41 | -48.2 | -84.25 | -988.83 | 3.36 | |||||
Common Equity, 1 Yr. Growth % | 43.12 | 11.17 | 1.29 | 17.05 | -12.02 | |||||
Cash From Operations, 1 Yr. Growth % | 31.55 | -2.83 | -19.95 | 15.12 | -4.47 | |||||
Capital Expenditures, 1 Yr. Growth % | 61.2 | -22.32 | -14.53 | 14.64 | 18.43 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -43.86 | 38.65 | 58.8 | -13.46 | 35.93 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -38.01 | 40.64 | 49.05 | -12.99 | 31.72 | |||||
Dividend Per Share, 1 Yr. Growth % | 5 | 4.76 | 4.55 | 4.35 | 8.33 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 32.37 | 24.28 | -3.68 | -6.68 | 2.02 | |||||
Gross Profit, 2 Yr. CAGR % | 29.91 | 22.22 | -5.2 | -6.8 | 2.42 | |||||
EBITDA, 2 Yr. CAGR % | 38.33 | 13.36 | -19.56 | -12.98 | 3.89 | |||||
EBITA, 2 Yr. CAGR % | 41.12 | 11.76 | -23.02 | -13.74 | 6.06 | |||||
EBIT, 2 Yr. CAGR % | 40.94 | 6.62 | -27.84 | -15.64 | 7.23 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 32.97 | -1.66 | -28.58 | -11.74 | -2.71 | |||||
Net Income, 2 Yr. CAGR % | 33.02 | -1.41 | -28.3 | -11.64 | -1.33 | |||||
Normalized Net Income, 2 Yr. CAGR % | 38.47 | 3.71 | -28.32 | -15.41 | 8.66 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 29.9 | -3.97 | -27.13 | -9.93 | -0.3 | |||||
Accounts Receivable, 2 Yr. CAGR % | 28.14 | 15.24 | -4.47 | -5.93 | 0.54 | |||||
Inventory, 2 Yr. CAGR % | 31.97 | 26.6 | 2.89 | 5.95 | 2.98 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 46.67 | 38.23 | -3.67 | 0.54 | -0.08 | |||||
Total Assets, 2 Yr. CAGR % | 74.3 | 65.36 | -0.31 | -1.53 | -5.41 | |||||
Tangible Book Value, 2 Yr. CAGR % | -29.36 | -54.25 | -71.44 | 18.32 | 203.1 | |||||
Common Equity, 2 Yr. CAGR % | 26.89 | 26.14 | 6.12 | 8.89 | 1.48 | |||||
Cash From Operations, 2 Yr. CAGR % | 31.23 | 13.06 | -11.8 | -4 | 4.87 | |||||
Capital Expenditures, 2 Yr. CAGR % | 35.26 | 11.9 | -18.52 | -1.01 | 16.52 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -11.43 | -12.42 | 48.38 | 18.76 | -1.31 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -7.23 | -6.63 | 44.78 | 15.26 | -1.83 | |||||
Dividend Per Share, 2 Yr. CAGR % | 5.13 | 4.88 | 4.65 | 4.45 | 6.32 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 22.75 | 24.44 | 9.22 | -1.43 | -4.24 | |||||
Gross Profit, 3 Yr. CAGR % | 21.86 | 22.6 | 7.13 | -1.75 | -4.78 | |||||
EBITDA, 3 Yr. CAGR % | 26.82 | 21.42 | -3.85 | -10.86 | -8.44 | |||||
EBITA, 3 Yr. CAGR % | 28.65 | 21.89 | -6.62 | -12.21 | -8.84 | |||||
EBIT, 3 Yr. CAGR % | 28.61 | 19.09 | -11.37 | -15.42 | -9.84 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 25.25 | 10.96 | -13.9 | -15.56 | -14.51 | |||||
Net Income, 3 Yr. CAGR % | 25.29 | 11.09 | -13.6 | -15.43 | -13.55 | |||||
Normalized Net Income, 3 Yr. CAGR % | 27.58 | 16.72 | -12.79 | -15.84 | -8.9 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 23.76 | 9.05 | -13.95 | -14.57 | -11.77 | |||||
Accounts Receivable, 3 Yr. CAGR % | 18.4 | 18.42 | 6.22 | -3.64 | -3.02 | |||||
Inventory, 3 Yr. CAGR % | 22.94 | 21.44 | 18.16 | 4.9 | 2.97 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 42.73 | 27.87 | 22.19 | -0.59 | -1.59 | |||||
Total Assets, 3 Yr. CAGR % | 52.79 | 47.43 | 37.09 | 0.76 | -5.53 | |||||
Tangible Book Value, 3 Yr. CAGR % | -11.56 | -36.3 | -67.93 | -10.16 | 13.11 | |||||
Common Equity, 3 Yr. CAGR % | 24.69 | 21.42 | 17.24 | 9.64 | 1.42 | |||||
Cash From Operations, 3 Yr. CAGR % | 24.05 | 18.72 | 0.77 | -3.61 | -4.16 | |||||
Capital Expenditures, 3 Yr. CAGR % | 27.23 | 12.43 | 2.29 | -8.69 | 5.08 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -4.65 | 2.34 | 6.8 | 25.05 | 16.65 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -1.79 | 6.57 | 9.12 | 23.17 | 13.74 | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.27 | 5.01 | 4.77 | 4.55 | 5.73 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 16.8 | 16.38 | 11.4 | 10.91 | 6.28 | |||||
Gross Profit, 5 Yr. CAGR % | 16.21 | 15.83 | 10.21 | 9.86 | 5.22 | |||||
EBITDA, 5 Yr. CAGR % | 18.88 | 14.71 | 5.71 | 6.27 | -0.27 | |||||
EBITA, 5 Yr. CAGR % | 20.24 | 15.28 | 4.76 | 6.14 | -1.1 | |||||
EBIT, 5 Yr. CAGR % | 19.95 | 13.75 | 2.07 | 3.75 | -3.59 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 22.51 | 11.41 | 0.05 | 1.26 | -9.58 | |||||
Net Income, 5 Yr. CAGR % | 22.58 | 11.49 | 0.22 | 1.37 | -8.89 | |||||
Normalized Net Income, 5 Yr. CAGR % | 19.55 | 13.02 | 1.21 | 2.62 | -4.05 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 21.49 | 10.32 | 0.13 | 1.02 | -8.73 | |||||
Accounts Receivable, 5 Yr. CAGR % | 12.59 | 11.3 | 8.66 | 8 | 3.91 | |||||
Inventory, 5 Yr. CAGR % | 18.26 | 16.5 | 14.49 | 14.99 | 11.84 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 24.55 | 23.79 | 21.96 | 16.15 | 12.74 | |||||
Total Assets, 5 Yr. CAGR % | 30.05 | 29.23 | 28.8 | 25.45 | 18.18 | |||||
Tangible Book Value, 5 Yr. CAGR % | -5.55 | -20.57 | -43.73 | -18.4 | -21.25 | |||||
Common Equity, 5 Yr. CAGR % | 15.57 | 15.42 | 16.9 | 16.24 | 10.66 | |||||
Cash From Operations, 5 Yr. CAGR % | 19.33 | 18.38 | 8.23 | 9.05 | 2.39 | |||||
Capital Expenditures, 5 Yr. CAGR % | 17.93 | 9.84 | 6.46 | 6.85 | 7.76 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 1.7 | 7.08 | 13.47 | 8.61 | 4.02 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 3.61 | 9.56 | 14.7 | 9.96 | 5.11 | |||||
Dividend Per Share, 5 Yr. CAGR % | 5.59 | 5.29 | 5.02 | 4.78 | 5.39 |
- Stock Market
- Equities
- DIA Stock
- Financials DiaSorin S.p.A.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















